Shorla Oncology raises $35m funding to further develop oncology products
The funding round was spearheaded by Kurma Partners' Growth Opportunities Fund, with active involvement from established investors like…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Oct 23
The funding round was spearheaded by Kurma Partners' Growth Opportunities Fund, with active involvement from established investors like…
05 Oct 23
AnemoCheck Home is the only FDA-cleared home anemia test with instant results
05 Oct 23
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its QuantiFERON-EBV RUO (Research Use Only)…
05 Oct 23
The program is designed to help patients access treatment, providing prescription fulfillment services, insurance benefits investigation, educational support,…
05 Oct 23
Featured presentations highlight how Seven Bridges delivers flexibility, compatibility and collaboration in support of key initiatives like AI/ML…
05 Oct 23
The second IDE Study will be conducted for the safety and efficacy for the treatment of knee OA…
04 Oct 23
POINT has two potential candidates in late-phase development, with several others in earlier stages of development, operates a…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
04 Oct 23
According to the agreement, both firms will co-fund current and future research and development expenditures with Sanofi paying…
04 Oct 23
The expanded collaboration combines Intellia’s genome editing platform with Regeneron’s proprietary antibody-targeted viral vector delivery technologies to develop…
04 Oct 23
The United Nations’ health agency will consider the SAGE’s recommendation and revise its position paper on dengue vaccines…